This compound is a synthetic intermediate used in the preparation of entecavir, a nucleoside analogue pharmaceutical active against hepatitis B virus. It features multiple aromatic rings and protective functional groups typical for multi-step organic synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 142217-78-5
(3R,4S)-3-FLUOROOXAN-4-OL
pharmaceutical intermediate
Linaclotide Impurity 3(Acylated Linaclotide)
pharmaceutical intermediate
1-boc-3-cyanoazetidine
pharmaceutical intermediate
1-N-Boc-3-Azetidinecarboxylic acid
pharmaceutical intermediate
(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol
ZLWZEFPIJWNPCO-ABKHIKNWSA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NC4=NC5=C(C(=N4)OCC6=CC=CC=C6)N=CN5[C@H]7C[C@@H]([C@H]([C@@H]7O)COCC8=CC=CC=C8)OCC9=CC=CC=C9